JP2019501363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501363A5 JP2019501363A5 JP2018516113A JP2018516113A JP2019501363A5 JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5 JP 2018516113 A JP2018516113 A JP 2018516113A JP 2018516113 A JP2018516113 A JP 2018516113A JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- protein
- reactive probe
- moiety
- reactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 27
- 235000018102 proteins Nutrition 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 18
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 14
- 235000018417 cysteine Nutrition 0.000 claims 14
- 239000000523 sample Substances 0.000 claims 13
- 150000003384 small molecules Chemical group 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 5
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- -1 N-hydroxysuccinimide (NHS) ester Chemical class 0.000 claims 3
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 claims 2
- 150000001345 alkine derivatives Chemical group 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- VHRUMKCAEVRUBK-GODQJPCRSA-N 15-deoxy-Delta(12,14)-prostaglandin J2 Chemical compound CCCCC\C=C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O VHRUMKCAEVRUBK-GODQJPCRSA-N 0.000 claims 1
- 102000004506 Blood Proteins Human genes 0.000 claims 1
- 108010017384 Blood Proteins Proteins 0.000 claims 1
- 108010078791 Carrier Proteins Proteins 0.000 claims 1
- 108091006146 Channels Proteins 0.000 claims 1
- 102000034573 Channels Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 claims 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 108091005764 adaptor proteins Proteins 0.000 claims 1
- 102000035181 adaptor proteins Human genes 0.000 claims 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000005262 alkoxyamine group Chemical group 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 150000001718 carbodiimides Chemical class 0.000 claims 1
- 210000004292 cytoskeleton Anatomy 0.000 claims 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 1
- 125000005179 haloacetyl group Chemical group 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 claims 1
- 238000000575 proteomic method Methods 0.000 claims 1
- 108091006024 signal transducing proteins Proteins 0.000 claims 1
- 102000034285 signal transducing proteins Human genes 0.000 claims 1
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562244881P | 2015-10-22 | 2015-10-22 | |
| US62/244,881 | 2015-10-22 | ||
| US201662345710P | 2016-06-03 | 2016-06-03 | |
| US62/345,710 | 2016-06-03 | ||
| PCT/US2016/058308 WO2017070611A1 (en) | 2015-10-22 | 2016-10-21 | Cysteine reactive probes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501363A JP2019501363A (ja) | 2019-01-17 |
| JP2019501363A5 true JP2019501363A5 (enExample) | 2020-01-30 |
| JP6953400B2 JP6953400B2 (ja) | 2021-10-27 |
Family
ID=58558160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018516113A Active JP6953400B2 (ja) | 2015-10-22 | 2016-10-21 | システイン反応性プローブとその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10670605B2 (enExample) |
| EP (1) | EP3365686A4 (enExample) |
| JP (1) | JP6953400B2 (enExample) |
| CA (1) | CA3001847A1 (enExample) |
| WO (1) | WO2017070611A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3033625B1 (en) | 2013-08-13 | 2020-01-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| WO2017070611A1 (en) * | 2015-10-22 | 2017-04-27 | The Scripps Research Institute | Cysteine reactive probes and uses thereof |
| KR102444509B1 (ko) | 2016-05-18 | 2022-09-19 | 미라티 테라퓨틱스, 인크. | Kras g12c 억제제 |
| WO2017210600A1 (en) * | 2016-06-03 | 2017-12-07 | The Scripps Research Institute | Compositions and methods of modulating immune response |
| EP3570829A4 (en) | 2017-01-18 | 2021-03-10 | The Scripps Research Institute | PHOTOREACTIVE LIGANDS AND USES |
| WO2018144869A1 (en) * | 2017-02-03 | 2018-08-09 | The Regents Of The University Of California | Compositons and methods for modulating uba5 |
| KR20190126074A (ko) * | 2017-02-03 | 2019-11-08 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 레티쿨론 4를 억제하기 위한 조성물 및 방법 |
| MX2019009199A (es) * | 2017-02-03 | 2019-10-21 | Univ California | Composiciones y métodos para modular ppp2r1a. |
| WO2019067733A1 (en) * | 2017-09-27 | 2019-04-04 | Vividion Therapeutics, Inc. | COMPOUNDS AND METHODS FOR MODULATING PROTEIN DEGRADATION |
| WO2019067741A1 (en) * | 2017-09-27 | 2019-04-04 | The Scripps Research Institute | CONJUGATED PROTEINS AND USES THEREOF |
| US10807951B2 (en) | 2017-10-13 | 2020-10-20 | The Regents Of The University Of California | mTORC1 modulators |
| EA202091186A1 (ru) | 2017-11-15 | 2020-10-01 | Мирати Терапьютикс, Инк. | ИНГИБИТОРЫ KRas G12C |
| US10647715B2 (en) | 2017-11-15 | 2020-05-12 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| WO2019113724A1 (zh) * | 2017-12-11 | 2019-06-20 | 广州君赫生物科技有限公司 | 双硫仑的新应用 |
| US11932633B2 (en) | 2018-05-07 | 2024-03-19 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| JP2022500385A (ja) | 2018-09-10 | 2022-01-04 | ミラティ セラピューティクス， インコーポレイテッド | 組み合わせ療法 |
| CA3112043A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| PT3849537T (pt) | 2018-09-10 | 2025-01-22 | Mirati Therapeutics Inc | Terapêuticas de combinação |
| CA3112129A1 (en) | 2018-12-05 | 2020-06-11 | Mirati Therapeutics, Inc. | Combination therapies |
| EP3908283A4 (en) | 2019-01-10 | 2022-10-12 | Mirati Therapeutics, Inc. | KRAS G12C INHIBITORS |
| EP3924348A4 (en) | 2019-03-21 | 2023-03-22 | University of Virginia Patent Foundation | SULFUR HETEROCYCLENE EXCHANGE CHEMISTRY AND ITS USES |
| JP7586894B2 (ja) * | 2019-08-05 | 2024-11-19 | ブリッドジーン バイオサイエンシズ インコーポレイテッド | 共有結合リガンドのプロテオームワイドな発見のための方法およびその組成物 |
| KR20220071193A (ko) | 2019-08-29 | 2022-05-31 | 미라티 테라퓨틱스, 인크. | Kras g12d 억제제 |
| US11890285B2 (en) | 2019-09-24 | 2024-02-06 | Mirati Therapeutics, Inc. | Combination therapies |
| US20230236170A1 (en) * | 2019-10-15 | 2023-07-27 | Jnana Therapeutics Inc. | Reactive affinity probe-interaction discovery platform |
| CA3161949A1 (en) * | 2019-10-16 | 2021-04-22 | The Scripps Research Institute | An activity-guided map of electrophile-cysteine interactions in primary human immune cells |
| WO2021076703A1 (en) * | 2019-10-16 | 2021-04-22 | Vividion Therapeutics, Inc. | Compounds and methods for modulating immune-related proteins |
| CN111063389B (zh) * | 2019-12-04 | 2021-10-29 | 浙江工业大学 | 一种基于深度卷积神经网络的配体绑定残基预测方法 |
| CN115135315B (zh) | 2019-12-20 | 2024-11-26 | 米拉蒂治疗股份有限公司 | Sos1抑制剂 |
| MX2023002942A (es) | 2020-09-11 | 2023-05-22 | Mirati Therapeutics Inc | Formas cristalinas de un inhibidor de kras g12c. |
| CN112255396A (zh) * | 2020-10-15 | 2021-01-22 | 南开大学 | 一种测量小分子药物抑制蛋白核酸互作的单分子力学方法 |
| CA3198885A1 (en) | 2020-12-15 | 2022-06-23 | Xiaolun Wang | Azaquinazoline pan-kras inhibitors |
| US11999753B2 (en) | 2020-12-16 | 2024-06-04 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-KRas inhibitors |
| WO2022240966A1 (en) * | 2021-05-11 | 2022-11-17 | Opna Immuno-Oncology Sa | Compounds and methods for yap/tead modulation and indications therefor |
| US20250034216A1 (en) * | 2021-11-22 | 2025-01-30 | The Scripps Research Institute | Stereoselective covalent ligands for oncogenic and immunological proteins |
| WO2024059575A2 (en) * | 2022-09-12 | 2024-03-21 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Composition, device, system, and methods for detecting environmental toxicants |
| WO2024073486A2 (en) * | 2022-09-28 | 2024-04-04 | The General Hospital Corporation | Probes and methods to identify ligandable fatty acylation sites for therapeutic target identification |
| CN116790698B (zh) * | 2023-06-21 | 2024-06-18 | 南京大学 | 基于氧化脱羧酶的硫醛合成方法及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344330B1 (en) | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
| AU5477100A (en) * | 1999-06-10 | 2001-01-02 | Pharmacia & Upjohn Company | Caspase-8 crystals, models and methods |
| JP3836791B2 (ja) * | 2000-11-21 | 2006-10-25 | サネシス ファーマシューティカルズ， インコーポレイテッド | リガンドの迅速な同定のための拡張されたテザー化アプローチ |
| WO2005118833A2 (en) | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak) |
| US7935479B2 (en) | 2004-07-19 | 2011-05-03 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
| WO2008094205A2 (en) * | 2006-08-04 | 2008-08-07 | The Board Of Trustees Of The Leland Stanford Junior University | A mild chemically cleavable linker system |
| US20100179118A1 (en) * | 2006-09-08 | 2010-07-15 | Dainippon Sumitomo Pharma Co., Ltd. | Cyclic aminoalkylcarboxamide derivative |
| CA2665223A1 (en) | 2006-10-02 | 2008-05-29 | The Scripps Research Institute | An enzyme regulating ether lipid signaling pathways |
| CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
| EP1947193A1 (en) | 2007-01-17 | 2008-07-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening method for anti-diabetic compounds |
| CA2679643A1 (en) * | 2007-03-09 | 2008-09-18 | The University Of British Columbia | Procaspase 8-mediated disease targeting |
| CA2716868A1 (en) * | 2008-02-26 | 2009-09-03 | Ludwig-Maximilians-Universitat Munchen | Beta-lactones as antibacterial agents |
| WO2013192364A1 (en) * | 2012-06-22 | 2013-12-27 | The University Of Vermont And State Agricultural College | Treatments of oxidative stress conditions |
| JP2016523236A (ja) | 2013-06-03 | 2016-08-08 | アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 多発性骨髄腫におけるヒストン脱アセチル化酵素（ｈｄａｃ）バイオマーカー |
| EP3033625B1 (en) * | 2013-08-13 | 2020-01-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| JP2017528448A (ja) | 2014-08-21 | 2017-09-28 | エスアールエックス カーディオ，エル エル シー | プロタンパク質コンバターゼであるスブチリシン／ケキシンタイプ９（ｐｃｓｋ９）のタンパク質活性のモジュレーションのための、結合リガンドとしての小分子の組成物およびその使用方法 |
| WO2017070611A1 (en) | 2015-10-22 | 2017-04-27 | The Scripps Research Institute | Cysteine reactive probes and uses thereof |
| EP3570829A4 (en) | 2017-01-18 | 2021-03-10 | The Scripps Research Institute | PHOTOREACTIVE LIGANDS AND USES |
-
2016
- 2016-10-21 WO PCT/US2016/058308 patent/WO2017070611A1/en not_active Ceased
- 2016-10-21 CA CA3001847A patent/CA3001847A1/en active Pending
- 2016-10-21 EP EP16858391.2A patent/EP3365686A4/en not_active Withdrawn
- 2016-10-21 US US15/331,745 patent/US10670605B2/en active Active
- 2016-10-21 JP JP2018516113A patent/JP6953400B2/ja active Active
-
2020
- 2020-06-02 US US16/890,966 patent/US20200292555A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501363A5 (enExample) | ||
| Mertins et al. | Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry | |
| Ostasiewicz et al. | Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry | |
| Bartoschik et al. | Near-native, site-specific and purification-free protein labeling for quantitative protein interaction analysis by MicroScale Thermophoresis | |
| Wittmann‐Liebold et al. | Two‐dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry | |
| Cordwell et al. | Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two‐dimensional electrophoresis gels | |
| Freeman et al. | Proteomics for protein expression profiling in neuroscience | |
| Chen et al. | Measuring the dynamics of E. coli ribosome biogenesis using pulse-labeling and quantitative mass spectrometry | |
| Honoré et al. | Functional genomics studied by proteomics | |
| ATE393912T1 (de) | Microarrays und ihre verwendungen | |
| Billakanti et al. | Simultaneous, quantitative detection of five whey proteins in multiple samples by surface plasmon resonance | |
| Haragan et al. | Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry | |
| ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
| Stigter et al. | Coupling surface-plasmon resonance and mass spectrometry to quantify and to identify ligands | |
| Salimi-Moosavi et al. | Rapid affinity measurement of protein–protein interactions in a microfluidic platform | |
| Campion et al. | Protein quantitation and analysis of purity | |
| JP2016535270A5 (enExample) | ||
| Burton et al. | Functionalizing tandem mass tags for streamlining click-based quantitative chemoproteomics | |
| Xu et al. | On‐plate enrichment of glycopeptides by using boronic acid functionalized gold‐coated Si wafer | |
| Haulenbeek et al. | Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance | |
| Bremer et al. | Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target | |
| CN103398988B (zh) | 一种基于不同种元素多离子态对比校正的libs金属元素定量方法 | |
| JP2005513507A5 (enExample) | ||
| Houfani et al. | Review of the real and sometimes hidden costs in proteomics experimental workflows | |
| EP1589341A2 (en) | Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures |